SHShih-Tsung Huang

Shih-Tsung Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shih-Tsung Huang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 25 July 2008
      • Vol. 28, 1985-8

    Evaluation of resistance index in patients with prostate cancer.

    by Shih-Tsung Huang, Ming-Li Hsieh

    The purpose of this study was to evaluate the relationship of the resistance index (RI) of the prostate measured by transrectal ultrasonography (TRUS) in Taiwanese prostate cancer patients to Gleason score, staging and prostate volume. Forty-five patients (mean age, 73.3 years; range 56 to 97) diagnosed to have prostate cancer via prostate biopsy and/or transurethral prostatectomy were recruited for our study. The patients were divided into 3 groups according to Gleason score, low grade (2-4, LG n = 14), intermediate grade (5-7, IG n = 14) and high grade (8-10, HG n = 17) groups. The blood flow pattern and mean RI of the prostate vessels were recorded and compared with age, prostate volume, serum prostate specific antigen (PSA) and oncological stage. A follow-up color Doppler ultrasonography was also performed in 17 patients after 3-6 months of hormone therapy and the changes of RI were recorded. The mean age, serum PSA and prostate volume were comparative among the three groups, but the differences of RI were statistically significant (p = 0.029). Advanced prostate cancer (HG group) tended to have higher RI. There was a close correlation between RI and Gleason score (Spearman R = 0.452, p = 0.002). The high RI phenomenon could be reversed after 3-6 months of hormone therapy (paired t-test, p < 0.05). High grade prostate cancer tends to have higher RI. RI measurement during color Doppler TRUS may be helpful in the evaluation of the vascularity of prostate cancer and its vascular changes to hormone treatment.


  • Open Access

    Duloxetine versus placebo for the treatment of women with stress predominant urinary incontinence in Taiwan: a double-blind, randomized, placebo-controlled trial

    by Alex Tong-Long Lin, Mou-Jong Sun, Hui-Lung Tai, Yao Chi Chuang, Shih-Tsung Huang, Nick Wang, Yan Daniel Zhao, Julie Beyrer, Meghan Wulster-Radcliffe, Louise Levine, et al.

    Background: This manuscript compares the efficacy and safety of duloxetine with placebo in Taiwanese women with SUI. Methods: Taiwanese women with SUI were were randomly assigned to placebo (n = 61) or duloxetine 80 mg/day (n = 60) in this double-blind, 8-week, placebo-controlled study. Outcome variables included: incontinence episode frequency (IEF), Incontinence Quality of Life questionnaire (I-QOL) scores, and Patient Global Impression of Improvement rating (PGI-I). Results: Decrease in IEF was significantly greater in duloxetine-treated than placebo-treated women (69.98% vs 42.56%, P < .001). No treatment differences in I-QOL scores were significant. There were significant differences in PGI-I rating. Treatment-emergent adverse events (TEAEs) were experienced by more duloxetine-treated than placebo-treated women (80.0% vs 44.3%; P < .001). Discontinuations due to adverse events were significantly greater for duloxetine-treated than placebo-treated women (26.7% vs 6.6%; P = .003). Conclusion: Data provide evidence for the safety and efficacy of duloxetine for the treatment for Taiwanese women with SUI. Trial Registration: ClinicalTrials.gov Identifier: NCT00475358


    • 1 February 2001
      • Vol. 24  (2) , 91-6

    Use of sildenafil citrate in treatment of Taiwanese men with erectile dysfunction: a single center experience.

    by S T Huang

    We evaluated the efficacy and safety of sildenafil citrate in the treatment of Taiwanese men with erectile dysfunction in the post-marketing era. From March 24, 1999 to September 30, 1999, we evaluated the efficacy and safety of Sildenafil in patients with erectile dysfunction. We used questions 3 and 4 of the International Index of Erectile Function (IIEF) as objective efficacy end-points. The patients used a home medication diary to record the subjective efficacy and side effects of sildenafil and their satisfaction with this drug as well as that of their sexual partners. There were 415 patients with erectile dysfunction in our survey. Their ages ranged from 29 to 85 years old with a mean of 60 years. Of these, 212 patients (51.1%) returned their home medication diaries. The satisfaction rate of these patients was 81.6% and the satisfaction rate of their sexual partners was 71.2%. About 71% of these patients achieved more than 60% rigidity. The most common side effect was facial flushing (45.8%), followed by dizziness (13.7%), visual disturbances (10.8%), headache (8%), nasal congestion (8%) and dyspepsia (4.7%). Sildenafil citrate is an effective oral medication for the treatment of erectile dysfunction in Taiwanese men. Our study noted more facial flushing and visual disturbances than other studies. These side effects were transient and well tolerated by most of the patients.

    • 1 December 1999
      • Vol. 22  (4)

    Use of a medical decision support system to improve the preoperative diagnosis of prostate cancer with pelvic lymph node metastases.

    by P L Chang, T M Wang, S T Huang, M L Hsieh, K H Tsui, R H Lai

    We evaluated the effects of a medical decision support system on the preoperative diagnosis of prostate cancer with pelvic lymph node metastases.


    • 1 September 1999
      • Vol. 22  (3)

    Does the use of clinical paths improve the efficiency and quality of care under the case payment system for inguinal herniorrhaphy or transurethral prostatectomy?

    by P L Chang, S T Huang, M L Hsieh, T M Wang, K H Tsui, R H Lai

    We evaluated the effects of implementing clinical paths for both inguinal herniorrhaphy (IH) and transurethral prostatectomy (TURP) on the efficiency and quality of medical care under the case payment system.

    • 1 June 1999
      • Vol. 161  (6) , 1858-62

    Effects of implementation of 18 clinical pathways on costs and quality of care among patients undergoing urological surgery.

    by P L Chang, T M Wang, S T Huang, M L Hsieh, K H Tsui, R H Lai

    We evaluated the effects on the costs and quality of care of implementation of 18 clinical pathways for urological operations. From April 1997 to March 1998 patients undergoing 1 of 18 urological operations were treated according to clinical pathways. The outcomes in terms of length of hospital stay and admission charges of these patients were compared with those of patients treated between April 1996 and March 1997 before clinical pathways were implemented. We also selected 7 clinically relevant quality indicators to assess the quality of care before and after clinical pathway implementation. Of the 1,784 patients undergoing urological surgery from April 1997 to March 1998, 1,382 (77.5%) were treated according to 1 of the 18 clinical pathways. Before implementation 1,279 of 1,615 patients (79.2%) underwent these procedures. The length of hospital stay decreased from 5.5 to 4.9 days (p < 0.01) and the average hospital admission charges decreased by 12.9% (p < 0.01) after implementation. Five of the quality indicators, including the rate of surgical complications, were significantly improved after pathway implementation. The hospitalization rate was not affected (1.3 before versus 0.8% after implementation, p = 0.18). Variations from the clinical pathways occurred in 543 cases (39.3%) and affected the length of hospital stay only (11.6%) or the admission charge only (12.9%) more often than both (7.8%, p < 0.01) or neither (7.0%, p < 0.01). The most common variances in these patients were patient related (30.8%). Implementation of multiple clinical pathways in a urology department can improve urological practice by decreasing the length of hospital stay, admission charges and rate of surgical complications, and by improving the quality of care.


    • 1 December 1998
      • Vol. 21  (4)

    Squamous cell carcinoma of the bladder: a ten-year retrospective study.

    by T M Wang, P L Chang, S T Huang, M L Hsieh, K H Tsui

    There is a limited amount of information available on treatment efficacy and optimal management of squamous cell carcinoma of bladder. The goal of this study was to assess the long-term outcome of patients with squamous cell carcinoma of the bladder treated using different modalities.


    • 1 August 1998
      • Vol. 160  (2) , 402-5

    The early effect of pelvic floor muscle exercise after transurethral prostatectomy.

    by P L Chang, L H Tsai, S T Huang, T M Wang, M L Hsieh, K H Tsui

    We evaluate the early effect of pelvic floor muscle exercise on the frequency of urination, terminal dribbling, urinary incontinence and satisfaction with life in patients after transurethral prostatectomy. From February to October 1996, 50 patients who had undergone transurethral prostatectomy were selected for study. The first 25 men served as a control group and the next 25 were the experimental group. Pelvic floor muscle exercise was started after removal of the Foley catheter postoperatively in the experimental group. The patients were evaluated before pelvic floor muscle exercise and weekly at our outpatient department after discharge from the hospital. Results for the later 25 patients treated with the pelvic floor muscle exercise program were compared to those of the prior 25 patients. There was a statistically significant difference (p <0.05) in the strength of pelvic floor muscle contractions at 4 weeks, length of between void interval (p <0.01), terminal dribbling at week 4 (p <0.05) and urinary incontinence at weeks 3 and 4 between the 2 groups after pelvic floor muscle exercise. During this study no complication or mortality occurred and there were no cases of hospitalization for either group. After pelvic floor muscle exercise patients in the experimental group had better satisfaction with life than the control group (p <0.01). We conclude that pelvic floor muscle exercise seems to help reduce symptoms within the first 4 weeks after transurethral prostatectomy, and provides better psychological and social quality of life.


    • 1 January 1997
      • Vol. 157  (1) , 177-83

    Use of the transurethral prostatectomy clinical path to monitor health outcomes.

    by P L Chang, S T Huang, M L Hsieh, T M Wang, J I Chen, H H Kuo, Y C Chuang, C H Chang

    We evaluated the effect on cost and medical care quality of use of the transurethral prostatectomy clinical path. Results in 100 patients treated when the transurethral prostatectomy clinical path was used were compared to those of 100 treated by the same physicians before implementation of this path. After implementation of the transurethral prostatectomy clinical path the length of hospital stay was significantly decreased from 5.9 to 5.0 days (p < 0.01) and Foley catheterization time was significantly decreased from 3.13 to 2.84 days (p < 0.01). Antibiotics were routinely used from the day before surgery to the day of hospital discharge as required by patient conditions. Therefore, a shorter hospital stay will significantly decrease the use of antibiotics. After implementation of the clinical path the average admission charges were decreased significantly by 17% (p < 0.01). Although some results from use of this path will not significantly affect costs, they will reflect some quality improvement. The effect of clinical path implementation on length of hospital stay between patients treated by junior and senior attending physicians was not significant. However, there was a statistically significant difference (p < 0.01) between results obtained by junior and senior attending physicians regarding average admission charges. Implementation of the transurethral prostatectomy clinical path can improve health care outcome by decreasing length of stay and admission charges, and improving quality of medical care, particularly for patients treated by junior attending physicians.